Protecting Democracy [1]

American democracy is in jeopardy, from the disastrous Citizens United ruling that flooded our politics with corporate cash to the immoral assault on voting rights. We work every day to defend against these threats and advance bold reforms.

Tell Congress: Pass the Protecting Our Democracy Act

Add Your Name

Coalition Calls on Americans to Reject Trump’s Threat to the Rule of Law and U.S. Democracy

Working With The Not Above the Law Coalition to Call for January 6th Justice
Making Government Work [2]

The U.S. government should work for the public, not corporations or industry. It should safeguard consumers, workers and the environment, and be funded well enough to do so. The budget process must not be obstructed by partisanship.

Get Corporate Money Out of Politics

Sign the Petition

It’s Time to Cut the Bloated Pentagon Budget to Fund People, Not Military Contractors

Ensuring Public Money Does Not Go To Private Equity
Consumer & Worker Safeguards [3]

Every day, big banks, big polluters, and big tech companies are threatening our economy, our environment, and our democracy – sacrificing Main Street Americans and our families on the altar of corporate profits. Public Citizen advocates for ordinary people by taking on corporate interests and their cronies in government.

Don’t Let Big Tech Write Our Digital Privacy Laws

Sign Now

A.I. Is Already Harming Democracy, Competition, Consumers, Workers, Climate, and More

Twitter Likely Violated Consent Decree, Public Citizen Tells FTC, DOJ
Safe & Affordable Drugs & Devices [4]

Prescription drugs are unaffordable and new drugs and devices often are approved without being proven safe and effective. Public Citizen challenges Big Pharma, device manufacturers and federal regulators to make drugs and medical devices safe, effective and accessible to all.

Fight Pharma Greed

Take Action Now
Health Care [5]

Health care in the U.S. leaves too many people out, costs too much and doesn’t meet acceptable standards of quality. Much of the care that we get is unaffordable, unnecessary or harmful. Public Citizen advocates Medicare for All, stronger oversight of dangerous doctors and safe clinical trials.

Win Medicare for All

Take Action Now

Report: Ranking of the Rate of State Medical Boards’ Serious Disciplinary Actions, 2017-2019

Statement: FDA Must Reject Tanezumab as a Treatment for Osteoarthritis Due to Unacceptable Dangers, Little to No Benefit
Globalization & Trade [6]

Our Mission

Global Trade Watch’s mission is to ensure that in this era of globalization, a majority have the opportunity to enjoy economic security, a healthy environment, safe food, medicines and products, access to quality affordable services such as health care and the exercise of democratic decision-making about the matters that affect our lives. Global Trade Watch has led the fight against corporate-rigged “trade” agreements that provide special powers for Big Pharma to raise medicine prices, promote the outsourcing of jobs to low-wage countries and undermine the food safety and other safeguards on which our families rely. For decades, we have fought for progressive alternatives that benefit people and the planet.

President Biden: No Secrecy in Indo-Pacific Trade Talks

Take Action

Climate Peace Clause Needed to Stop Trade Attacks on Climate Policies

Big Tech’s “Digital Trade” Power-Grab
Climate & Energy [7]

The climate crisis is the challenge of our time. We can fix it with solutions that will make us healthier and more economically secure. We must act quickly to make our economy run on renewable power — and ensure that disadvantaged families and displaced workers share equitably in the new economy. We also must fight the corrupting power of fossil fuel companies and ensure that energy regulators are effective and publicly accountable.

Tell Toyota: Go all-in on EVs

Add Your Name

Climate Roadmap for U.S. Financial Regulation

Toyota’s Troubling Electric Vehicle Track Record
Justice & the Courts [8]

Litigation can remedy or deter wrongdoing, impact policy and meaningfully slow abuses of power. Whether suing on behalf of our members to ensure the honest functioning of government, or representing individual consumers seeking redress in court, our litigation draws on our expertise in administrative law, constitutional law, and government transparency.

Subscribe to the Supreme Court Conference Preview

Sign Up

Advocating safer, more effective and affordable drugs

Since our founding in 1971, Public Citizen has worked to ensure the safety and effectiveness of prescription drugs. When the pharmaceutical industry provides false or misleading information to doctors or patients, we act. We have helped force dozens of dangerous drugs off the market and ensured stronger warnings on many others.

What you can do

Fight Pharma Greed

Tell your rep to allow the government to negotiate lower prescription drug prices for Medicare Part D.

Take Action Now

Join the Movement

Get plugged into our campaigns to hold the powerful accountable.

Get Involved

Tell President Biden: Make Meds Affordable

President Biden must end the monopoly power of Big Pharma

SEND AN EMAIL

Our Work

Using research, analysis, petitions, and media outreach, our doctors and medical experts push to have dangerous medications taken off the market or their use limited.

Sounding the Alarm on Dangerous Gout Medication

Public Citizen urged the FDA to remove from the market the widely-used gout medication febuxostat because it poses unique, serious risks and offers no unique benefit.

Seeking a Ban of Dangerous Chemical Promoted to Treat Cancer

We successfully petitioned the FDA to ban pharmacy compounding of cesium chloride because it does not treat or prevent cancer and is unsafe for human use.

27 Years of Pharmaceutical Industry Criminal & Civil Penalties

Report: Federal criminal penalties for lawbreaking pharma corporations have plummeted while prosecutions of company executives remain rare.

Testimony before the FDA’s Gastrointestinal Drugs Advisory Committee regarding the possible accelerated approval of obeticholic acid (NDA# 212833) to treat nonalcoholic steatohepatitis with fibrosis

May 19, 2023

Litigation

Braidwood Management Inc. v. Becerra

Testimony before the FDA’s Cellular, Tissue and Gene Therapies Advisory Committee Regarding SRP-9001 (delandistrogene moxeparvovec) for the Treatment of Duchenne Muscular Dystrophy

May 12, 2023

Press Releases

Stay Updated on Drugs

Follow Public Citizen

Support Our Work

Donate

Tell Congress: Pass the Protecting Our Democracy Act

Coalition Calls on Americans to Reject Trump’s Threat to the Rule of Law and U.S. Democracy

Working With The Not Above the Law Coalition to Call for January 6th Justice

Get Corporate Money Out of Politics

It’s Time to Cut the Bloated Pentagon Budget to Fund People, Not Military Contractors

Ensuring Public Money Does Not Go To Private Equity

Don’t Let Big Tech Write Our Digital Privacy Laws

A.I. Is Already Harming Democracy, Competition, Consumers, Workers, Climate, and More

Twitter Likely Violated Consent Decree, Public Citizen Tells FTC, DOJ

Fight Pharma Greed

Win Medicare for All

Report: Ranking of the Rate of State Medical Boards’ Serious Disciplinary Actions, 2017-2019

Statement: FDA Must Reject Tanezumab as a Treatment for Osteoarthritis Due to Unacceptable Dangers, Little to No Benefit

President Biden: No Secrecy in Indo-Pacific Trade Talks

Climate Peace Clause Needed to Stop Trade Attacks on Climate Policies

Big Tech’s “Digital Trade” Power-Grab

Tell Toyota: Go all-in on EVs

Climate Roadmap for U.S. Financial Regulation

Toyota’s Troubling Electric Vehicle Track Record

Subscribe to the Supreme Court Conference Preview

What you can do

Fight Pharma Greed

Join the Movement

Tell President Biden: Make Meds Affordable

Our Work

Sounding the Alarm on Dangerous Gout Medication

Seeking a Ban of Dangerous Chemical Promoted to Treat Cancer

27 Years of Pharmaceutical Industry Criminal & Civil Penalties

Testimony before the FDA’s Gastrointestinal Drugs Advisory Committee regarding the possible accelerated approval of obeticholic acid (NDA# 212833) to treat nonalcoholic steatohepatitis with fibrosis

Braidwood Management Inc. v. Becerra

Testimony before the FDA’s Cellular, Tissue and Gene Therapies Advisory Committee Regarding SRP-9001 (delandistrogene moxeparvovec) for the Treatment of Duchenne Muscular Dystrophy

FDA Should Reject Approval of Dangerous Antipsychotic to Prevent Harm to Agitated Patients with Alzheimer’s Dementia

Letter to the FDA Opposing Approval of Brexpiprazole for the Treatment of Agitation Associated with Alzheimer’s Dementia

Alliance for Hippocratic Medicine v. FDA

Product Recalls: March 15, 2023 – April 12, 2023

Public Citizen’s Health Letter

Petition: FDA Should Promptly Add Banned Medication to List of Withdrawn Drugs to Prevent Pharmacy Compounding

Stay Updated on Drugs

Follow Public Citizen

Support Our Work